Vaishali Pharma Ltd

Vaishali Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaishali Pharma Ltd

₹ 7.76 -0.13%
24 Jul - close price
Company website NSE: VAISHALI
About

Incorporated in 1989, Vaishali Pharma Ltd
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ Brands including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations

Website NSE - BE
  • Market Cap ₹ 101 Cr.
  • Current Price ₹ 7.76
  • High / Low ₹ 13.1 / 4.75
  • Stock P/E 25.1
  • Book Value ₹ 5.29
  • Dividend Yield 0.00 %
  • ROCE 8.90 %
  • ROE 6.02 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 31.6%
  • Company has a low return on equity of 3.43% over last 3 years.
  • Earnings include an other income of Rs.3.84 Cr.
  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
26.24 13.42 12.57 27.90 32.40 18.08 20.79 27.91 32.25 23.75 33.45 24.65 26.93
25.46 11.11 9.92 24.95 39.19 15.73 18.37 26.55 38.29 22.38 32.06 23.09 27.13
Operating Profit 0.78 2.31 2.65 2.95 -6.79 2.35 2.42 1.36 -6.04 1.37 1.39 1.56 -0.20
OPM % 2.97% 17.21% 21.08% 10.57% -20.96% 13.00% 11.64% 4.87% -18.73% 5.77% 4.16% 6.33% -0.74%
0.53 0.36 0.30 0.47 0.91 0.42 0.71 1.07 1.00 0.84 0.84 0.89 1.26
Interest 0.54 0.43 0.47 0.43 0.40 0.38 0.38 0.38 0.44 0.33 0.40 0.51 0.72
Depreciation 0.15 0.12 0.12 0.12 0.14 0.12 0.12 0.12 0.12 0.14 0.17 0.13 0.16
Profit before tax 0.62 2.12 2.36 2.87 -6.42 2.27 2.63 1.93 -5.60 1.74 1.66 1.81 0.18
Tax % 29.03% 25.00% 27.97% 26.13% -26.95% 25.11% 25.10% 24.87% -23.39% 26.44% 28.31% 28.18% -50.00%
0.44 1.59 1.70 2.11 -4.68 1.70 1.97 1.44 -4.29 1.28 1.18 1.30 0.27
EPS in Rs 0.04 0.15 0.16 0.20 -0.44 0.16 0.18 0.13 -0.40 0.12 0.09 0.10 0.02
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
95 67 64 68 75 60 54 76 70 86 99 109
95 66 60 65 73 59 51 69 60 85 98 105
Operating Profit -0 1 3 3 2 1 3 7 9 2 1 4
OPM % -0% 1% 5% 4% 3% 2% 5% 9% 13% 2% 1% 4%
4 3 1 2 2 2 2 2 2 2 3 4
Interest 3 3 3 3 3 3 3 2 2 2 2 2
Depreciation 0 0 0 0 0 0 0 0 0 1 0 1
Profit before tax 0 -0 1 1 1 0 1 6 9 1 1 5
Tax % -7% 300% 32% 41% 37% 62% 26% 30% 25% 23% 34% 25%
0 -0 1 1 1 0 1 4 7 1 1 4
EPS in Rs 0.20 -0.04 0.15 0.08 0.07 0.00 0.10 0.38 0.63 0.07 0.08 0.31
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 15%
3 Years: 16%
TTM: 10%
Compounded Profit Growth
10 Years: 63%
5 Years: 31%
3 Years: -15%
TTM: 391%
Stock Price CAGR
10 Years: %
5 Years: 14%
3 Years: -18%
1 Year: -37%
Return on Equity
10 Years: 6%
5 Years: 7%
3 Years: 3%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.50 0.50 3 7 7 11 11 11 11 11 26 26
Reserves 3 3 1 14 15 11 12 16 30 32 39 43
25 21 23 18 17 17 18 21 15 13 12 19
17 25 18 25 30 28 46 34 24 24 33 35
Total Liabilities 46 49 45 64 69 66 86 82 79 80 110 123
2 1 1 1 1 1 1 1 2 2 2 2
CWIP 0 0 0 0 0 0 0 0 1 1 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 5
44 48 43 62 67 64 84 80 76 77 107 116
Total Assets 46 49 45 64 69 66 86 82 79 80 110 123

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-4 5 0 -9 4 3 2 1 1 1 -18 0
2 3 1 1 -0 -0 -0 -1 0 1 -0 -5
2 -8 -1 8 -4 -3 -2 0 -2 -1 18 5
Net Cash Flow 0 0 -0 0 0 0 0 1 -0 1 0 -0
Free Cash Flow -5 5 0 -10 4 3 2 0 1 1 -18 -0
CFO/OP 1,252% 842% 16% -326% 212% 433% 78% 31% 28% 185% -3,104% 19%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 133 221 214 240 240 286 453 282 281 209 172 170
Inventory Days 13 20 7 11 5 6 5 4 20 2 20 13
Days Payable 66 145 100 136 130 169 321 163 120 95 116 81
Cash Conversion Cycle 80 96 121 115 115 123 137 122 181 116 77 102
Working Capital Days 98 25 14 97 98 124 146 111 208 169 231 212
ROCE % 14% 13% 16% 13% 10% 7% 10% 19% 22% 6% 5% 9%

Insights

In beta
Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Countries Exported To
count

Log in to view insights

Please log in to see hidden values.

Login
Export Revenue (FOB)
Rs. Crores
Formulation Brands Registered
count
Product Registrations Approved
count
Products in Portfolio
count
Customers
count
Product Registrations Applied
count
Distributors (Export)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
26.62% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 31.61% 31.61% 31.61% 30.54%
73.38% 73.68% 73.68% 73.67% 73.68% 73.68% 73.68% 73.68% 68.39% 68.39% 68.39% 69.46%
No. of Shareholders 9,1819,3909,47918,98327,54628,87428,68227,75227,14826,53426,67126,697

Documents

Announcements

Annual reports

DRHP

Concalls